NFKBIB
Basic information
Region (hg38): 19:38899700-38908893
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the NFKBIB gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 17 | 19 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 17 | 2 | 0 |
Variants in NFKBIB
This is a list of pathogenic ClinVar variants found in the NFKBIB region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-38900175-C-T | not specified | Uncertain significance (Jun 07, 2023) | ||
19-38900190-A-G | not specified | Uncertain significance (Nov 15, 2024) | ||
19-38905077-C-T | not specified | Uncertain significance (Jun 03, 2022) | ||
19-38905259-G-A | not specified | Uncertain significance (Oct 12, 2024) | ||
19-38905359-A-G | not specified | Uncertain significance (Sep 25, 2024) | ||
19-38905364-C-T | not specified | Uncertain significance (Dec 08, 2023) | ||
19-38905365-G-A | not specified | Uncertain significance (Feb 15, 2023) | ||
19-38905388-C-T | not specified | Uncertain significance (Jun 18, 2021) | ||
19-38905391-G-A | not specified | Likely benign (Jul 26, 2022) | ||
19-38905392-A-C | not specified | Uncertain significance (Dec 07, 2021) | ||
19-38905415-G-A | not specified | Uncertain significance (Jul 05, 2022) | ||
19-38905419-G-A | not specified | Likely benign (May 27, 2022) | ||
19-38905500-A-G | not specified | Uncertain significance (Apr 08, 2024) | ||
19-38905520-G-A | not specified | Uncertain significance (Jul 27, 2022) | ||
19-38907238-G-A | not specified | Uncertain significance (Jan 17, 2024) | ||
19-38907244-G-A | not specified | Uncertain significance (Dec 10, 2024) | ||
19-38907272-G-A | not specified | Likely benign (Sep 03, 2024) | ||
19-38907281-G-A | not specified | Uncertain significance (Apr 06, 2024) | ||
19-38907309-G-A | Likely benign (Jan 01, 2023) | |||
19-38907483-G-A | not specified | Uncertain significance (Oct 09, 2024) | ||
19-38907484-C-T | not specified | Uncertain significance (Apr 24, 2024) | ||
19-38907499-G-A | not specified | Uncertain significance (Aug 27, 2024) | ||
19-38907541-G-A | not specified | Uncertain significance (Jul 07, 2024) | ||
19-38907558-G-A | not specified | Uncertain significance (May 27, 2022) | ||
19-38907561-C-T | not specified | Uncertain significance (Jul 09, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
NFKBIB | protein_coding | protein_coding | ENST00000313582 | 6 | 9194 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.422 | 0.576 | 125703 | 0 | 18 | 125721 | 0.0000716 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.970 | 203 | 246 | 0.826 | 0.0000169 | 2261 |
Missense in Polyphen | 66 | 96.268 | 0.68558 | 976 | ||
Synonymous | -0.0624 | 110 | 109 | 1.01 | 0.00000813 | 774 |
Loss of Function | 2.72 | 3 | 13.9 | 0.215 | 7.74e-7 | 143 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000192 | 0.000192 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000164 | 0.000163 |
Finnish | 0.0000529 | 0.0000462 |
European (Non-Finnish) | 0.0000776 | 0.0000703 |
Middle Eastern | 0.000164 | 0.000163 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Inhibits NF-kappa-B by complexing with and trapping it in the cytoplasm. However, the unphosphorylated form resynthesized after cell stimulation is able to bind NF-kappa-B allowing its transport to the nucleus and protecting it to further NFKBIA- dependent inactivation. Association with inhibitor kappa B- interacting NKIRAS1 and NKIRAS2 prevent its phosphorylation rendering it more resistant to degradation, explaining its slower degradation.;
- Pathway
- Adipocytokine signaling pathway - Homo sapiens (human);T cell receptor signaling pathway - Homo sapiens (human);B cell receptor signaling pathway - Homo sapiens (human);Neurotrophin signaling pathway - Homo sapiens (human);Influenza A - Homo sapiens (human);Chemokine signaling pathway - Homo sapiens (human);Cytosolic DNA-sensing pathway - Homo sapiens (human);NOD-like receptor signaling pathway - Homo sapiens (human);Th17 cell differentiation - Homo sapiens (human);Th1 and Th2 cell differentiation - Homo sapiens (human);Leishmaniasis - Homo sapiens (human);Toxoplasmosis - Homo sapiens (human);Shigellosis - Homo sapiens (human);Measles - Homo sapiens (human);Epstein-Barr virus infection - Homo sapiens (human);RIG-I-like receptor signaling pathway - Homo sapiens (human);Herpes simplex infection - Homo sapiens (human);IL-1 signaling pathway;TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway;Prolactin Signaling Pathway;IL17 signaling pathway;TNF alpha Signaling Pathway;Apoptosis;Hair Follicle Development- Induction (Part 1 of 3);Apoptotic Signaling Pathway;RIG-I-like Receptor Signaling;Chemokine signaling pathway;TLR NFkB;Toll Like Receptor 7/8 (TLR7/8) Cascade;Signaling by Interleukins;hypoxia and p53 in the cardiovascular system;tumor suppressor arf inhibits ribosomal biogenesis;Cytokine Signaling in Immune system;Toll Like Receptor 9 (TLR9) Cascade;MyD88 cascade initiated on plasma membrane;Toll Like Receptor 10 (TLR10) Cascade;Toll Like Receptor 3 (TLR3) Cascade;Toll Like Receptor 5 (TLR5) Cascade;B cell receptor signaling;ZBP1(DAI) mediated induction of type I IFNs;Toll-Like Receptors Cascades;TRAF6 mediated NF-kB activation;DDX58/IFIH1-mediated induction of interferon-alpha/beta;Activation of NF-kappaB in B cells;Signaling by the B Cell Receptor (BCR);Interleukin-1 signaling;TCR;Innate Immune System;Immune System;Adaptive Immune System;Downstream signaling events of B Cell Receptor (BCR);IL-1 NFkB;RIP-mediated NFkB activation via ZBP1;TAK1 activates NFkB by phosphorylation and activation of IKKs complex;TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation;MyD88 dependent cascade initiated on endosome;BCR signaling pathway;TNFalpha;Cytosolic sensors of pathogen-associated DNA ;TRIF(TICAM1)-mediated TLR4 signaling ;MyD88-independent TLR4 cascade ;Toll Like Receptor 4 (TLR4) Cascade;TNF;MyD88:Mal cascade initiated on plasma membrane;Toll Like Receptor TLR1:TLR2 Cascade;Toll Like Receptor TLR6:TLR2 Cascade;Toll Like Receptor 2 (TLR2) Cascade;Interleukin-1 family signaling;CD4 T cell receptor signaling-NFkB cascade;CD4 T cell receptor signaling
(Consensus)
Recessive Scores
- pRec
- 0.640
Intolerance Scores
- loftool
- 0.149
- rvis_EVS
- -0.56
- rvis_percentile_EVS
- 19.73
Haploinsufficiency Scores
- pHI
- 0.512
- hipred
- Y
- hipred_score
- 0.701
- ghis
- 0.532
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.971
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Nfkbib
- Phenotype
- homeostasis/metabolism phenotype; immune system phenotype; skeleton phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype;
Gene ontology
- Biological process
- transcription, DNA-templated;signal transduction;cellular response to lipopolysaccharide;positive regulation of nucleic acid-templated transcription
- Cellular component
- nucleus;cytosol
- Molecular function
- transcription coactivator activity;protein binding